Faronem 200/ER 300 mg Tablet

Product overview for Faronem 200/ER 300 mg Tablet exporter requirements

Oddway International supports regulated B2B procurement of Faronem 200/ER 300 mg Tablet for hospitals, importers, distributors, and institutional buyers. As a Faronem 200/ER 300 mg Tablet exporter, we coordinate sourcing, documentation, and shipment planning subject to local regulations. Buyers seeking Faronem 200/ER 300 mg Tablet price support can request a commercial quotation based on destination, brand preference, and order scope.

Faronem 200/ER 300 mg Tablet contains faropenem, an oral beta-lactam antibacterial agent supplied only against valid institutional or regulatory requirements. Moreover, Oddway International works as a Pharmaceutical exporter from India for approved trade channels, tender supply, emergency access programs, and distributor-led procurement where permitted.

Therapeutic category/Drug classification

Faronem 200/ER 300 mg Tablet belongs to the antibacterial therapeutic category and is classified as an oral penem antibiotic. Healthcare professionals may prescribe it for susceptible bacterial infections as per approved indications in the destination market. However, use, dosage, and duration must remain under qualified medical supervision and applicable regulatory approval.

Commonly reported side effects may include nausea, abdominal discomfort, diarrhea, headache, rash, or altered laboratory parameters. Precautions apply for patients with beta-lactam allergy, renal impairment, gastrointestinal disorders, or a history of severe hypersensitivity. Additionally, prescribers should review drug interactions, including medicines that may affect renal clearance or increase adverse reaction risk.

Faronem 200/ER 300 mg Tablet price and minimum order quantity

The Faronem 200/ER 300 mg Tablet price depends on requested brand, quantity, export market, documentation needs, and shipping route. Oddway International provides formal quotations rather than public price listings. Therefore, buyers can compare Faronem 200/ER 300 mg Tablet cost for wholesale, institutional, or named patient requirements after sharing procurement details.

Minimum order quantity remains case-specific and depends on manufacturer availability, destination compliance, and logistics feasibility. As a bulk supplier Faronem 200/ER 300 mg Tablet partner, Oddway International supports consolidated procurement for importers, hospital groups, and government or private healthcare channels without suggesting uncontrolled supply.

Available strengths and packaging for Faronem 200/ER 300 mg Tablet generic supply

Faronem may be requested in 200 mg and ER 300 mg tablet presentations, subject to manufacturer and market availability. Buyers may also ask about Faronem 200/ER 300 mg Tablet generic alternatives where permitted by local regulations. Furthermore, packaging details, batch information, and shelf-life documentation can be verified before dispatch.

• Composition: faropenem-based oral antibacterial tablet, as applicable to the requested presentation.
• Dosage form: tablet or extended-release tablet, depending on requirement.
• Strength options: 200 mg and ER 300 mg, subject to availability.
• Supply basis: export, institutional procurement, or NPS where legally permitted.

Wholesale, export and named patient supply capabilities for bulk supplier Faronem 200/ER 300 mg Tablet

Oddway International serves distributors, hospital procurement teams, and licensed importers as a bulk supplier Faronem 200/ER 300 mg Tablet source from India. As a Pharmaceutical wholesaler, we support wholesale consolidation, vendor coordination, and shipment scheduling for approved B2B requirements.

For urgent or exceptional access needs, our team can coordinate through a named patient supplier model, subject to prescription, import permission, and country-specific rules. Consequently, buyers receive process guidance for documentation, compliance checks, and shipment readiness without patient-facing promotional claims.

Quality assurance and global standards for Faronem 200/ER 300 mg Tablet generic procurement

Oddway International follows supplier qualification and documentation review processes for Faronem 200/ER 300 mg Tablet generic and branded sourcing requests. We help buyers obtain COA, MSDS/SDS, invoice, packing list, and export documentation when applicable. Moreover, GDP-aligned handling practices support traceable movement across regulated and semi-regulated markets.

Quality checks may include brand verification, manufacturer confirmation, batch-level review, and packaging integrity checks before dispatch. However, final import approval remains subject to the buyer’s national authority, registered product status, and local compliance pathway.

Why source Faronem 200/ER 300 mg Tablet from Oddway International

Oddway International combines Indian market access with international pharmaceutical export experience. Buyers evaluating Faronem 200/ER 300 mg Tablet cost receive responsive coordination, clear documentation support, and destination-aware shipment planning. Additionally, our team manages communication with manufacturers, distributors, freight partners, and consignee representatives for smoother procurement execution.

We work with hospital chains, licensed importers, NGOs, clinics, and tender suppliers that require dependable B2B coordination. As a result, buyers can request the product through structured wholesale, institutional, or NPS channels where permitted.

International logistics and documentation Support for Faronem 200/ER 300 mg Tablet exporter shipments

As a Faronem 200/ER 300 mg Tablet exporter, Oddway International arranges export-ready paperwork and shipping coordination according to destination requirements. Our international medicine shipping support covers courier, air cargo, special handling, and documentation workflows where suitable.

Documentation may include commercial invoice, packing list, COA, MSDS/SDS, product details, and other export records requested by customs or import authorities. Furthermore, our logistics team monitors route feasibility, transit requirements, and consignee readiness to support compliant international movement.